EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Hemosphere, Inc., developer of the HeRO® Graft for hemodialysis access, announced that another sales record was achieved. Last week, Hemosphere sold the 4000th HeRO® Graft marking a new milestone in the company’s history.
